Xarelto Lawyers Announce New Website with Information on Filing Xarelto Lawsuits

Share Article

Attorneys handling Xarelto lawsuit claims for alleged internal bleeding and hemorrhagic stroke at the Onder Law Firm launch a new Xarelto Contingency Lawsuit website; a resource to the public, the website links consumers to no-cost, no-obligation Xarelto lawsuit case review.

A nationally-renowned law firm, respected for its achievements in pharmaceutical and product safety litigation, The Onder Law Firm is pleased to launch a new website, http://www.XareltoContingencyLawsuit.com. By providing comprehensive information on the risk of internal bleeding and stroke for patients taking Xarelto, the FDA Xarelto warning, and answers to questions frequently asked of Xarelto lawyers, the website serves as a public resource on Xarelto lawsuits and dangers.

Xarelto is similar to the drug Pradaxa in a variety of ways. According to a February 5, 2014 article in the New York Times, Xarelto and Pradaxa are two modern replacements for warfarin, and the two drug’s makers are scrambling to claim market shares that have been dominated by warfarin drugs since the 1950s. This new generation of blood thinners, which includes Xarelto, offers new convenience to patients by eliminating the need for dietary restrictions, regular blood tests, and frequent dosage adjustments.

The other chief similarity between the two drugs is that both have been blamed for causing serious adverse events in patients, according to the October 2012 edition of QuarterWatch from the Institute for Safe Medication Practices.** Similar to other blood thinners, ISMP reported, Xarelto makes patients prone to serious bleeding events. Based on clinical trials, 15% of patients were expected to experience bleeding problems each year, resulting in QuarterWatch naming anticoagulants as “among the riskiest of all outpatient drug treatments”.

Xarelto bleeding incidents were analyzed by QuarterWatch. According to the October 2012 edition, a large number of adverse events had been reported to the FDA, prompting the ISMP to probe deeper into the drug’s risks. Two complaints dominated the adverse events examined: first, that Xarelto was ineffective at preventing blood clots, and second, that the drug caused serious and unstoppable bleeding events. “The primary complaint seen has been lack of efficacy – reports of the very venous and pulmonary thromboembolisms and other serious blood-clot-related events that the drug is intended to prevent.” 44% of adverse events were thromboembolisms, and 34% were serious bleeds, or hemorrhages.

Plaintiffs have filed at least thirty Xarelto lawsuits which are pending in federal courts around the nation and a request to consolidate the cases into a Multidistrict Litigation has been submitted to the United States Judicial Panel on Multidistrict Litigation, according to court documents. The case, known as In Re: Xarelto Products Liability Litigation, MDL No. 2592 is still being considered. An initial request to consolidate the Xarelto lawsuits in the U.S. District Court’s Southern Illinois District has been opposed by the defendants’ attorneys. According to court documents, plaintiffs in Xarelto lawsuits raise the questions of “whether the label was accurate” to warn consumers of the risk of bleeding from Xarelto, “whether there was adequate testing” to prove the drug’s safety or detect risks, and “whether there was a breach of warranty”.

The Onder Law Firm is currently accepting inquiries from persons and families of persons who have suffered from serious bleeding and stroke while taking Xarelto. Xarelto lawyers are investigating these inquiries for possible Xarelto bleeding lawsuits. The Onder Law Firm has won major settlements for clients in the areas of drug and medical device recalls, as well as product and family safety. The firm is nationally-renowned for its work on window blind strangulation, and has notable expertise in fighting on behalf of individuals against powerful corporations. Persons and family members of persons who have suffered from bleeding, hemorrhage or stroke while taking Xarelto are eligible for a free evaluation with a Xarelto attorney, and may contact the firm through its Xarelto Contingency Lawsuit website.

The Onder Law Firm also welcomes Xarelto lawsuit inquiries from other law firms, either to handle these inquiries or work as co-counsel.

About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O’Leary & Peterson has represented clients throughout the United States, and other firms throughout the nation often seek its experience and expertise on complex litigation. It is a recognized leader in products liability cases such as window blind cord strangulation and pharmaceutical litigation. The Onder Law Firm’s Xarelto lawyers provide information to the public at http://www.xareltocontingencylawsuit.com/.

*nytimes.com/2014/02/06/business/study-of-blood-clot-drug-pradaxa-unnerved-its-maker-documents-suggest.html?_r=0
** ismp.org/quarterwatch/pdfs/2012Q1.pdf

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Gudeman
Gudeman Group
+1 (314) 614-8709
Email >
Visit website